The livers of the T2DM + SFFE + brusatol-treated rats showed a significant increase in the levels of Bax and caspase-3 and a significant reduction in the levels of Bcl2 as compared to the T2DM rats (Table 4). This evidence concerns the gene CASP3 and type 2 diabetes mellitus.